Mechanism and clinical significance of prostaglandin-induced iris pigmentation: Update on the use of prostaglandin analogs in glaucoma therapy

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Survey of ophthalmology 2002, Vol.47, p.S162-S175
Hauptverfasser: STJERNSCHANTZ, Johan W, ALBERT, Daniel M, HU, Dan-Ning, DRAGO, Filippo, WISTRAND, Per J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S175
container_issue
container_start_page S162
container_title Survey of ophthalmology
container_volume 47
creator STJERNSCHANTZ, Johan W
ALBERT, Daniel M
HU, Dan-Ning
DRAGO, Filippo
WISTRAND, Per J
description
format Article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_13872582</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>13872582</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_138725823</originalsourceid><addsrcrecordid>eNqNjLsOgjAUQBujifj4hy6OTQoFgdloXHRyJ01p8ZpyaXpx8O_t4Ac4nTOcnAXL8qZuhVKyXLJMStWKY1HVa7YhekkpS9XWGbvfrHlqBBq5xp4bDwhGe04wILikaCyfHA9xolkPPkWAArB_G9tziEA8wDBanPUME-7YymlPdv_jlh0u58fpKoKmtHUx_YC6EGHU8dPlqqmLqinUv90XWBBCZw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Mechanism and clinical significance of prostaglandin-induced iris pigmentation: Update on the use of prostaglandin analogs in glaucoma therapy</title><source>Elsevier ScienceDirect Journals</source><creator>STJERNSCHANTZ, Johan W ; ALBERT, Daniel M ; HU, Dan-Ning ; DRAGO, Filippo ; WISTRAND, Per J</creator><creatorcontrib>STJERNSCHANTZ, Johan W ; ALBERT, Daniel M ; HU, Dan-Ning ; DRAGO, Filippo ; WISTRAND, Per J</creatorcontrib><identifier>ISSN: 0039-6257</identifier><identifier>EISSN: 1879-3304</identifier><identifier>CODEN: SUOPAD</identifier><language>eng</language><publisher>New York, NY: Elsevier Science</publisher><subject>Biological and medical sciences ; Drug toxicity and drugs side effects treatment ; Eye ; Medical sciences ; Pharmacology. Drug treatments ; Toxicity: eye</subject><ispartof>Survey of ophthalmology, 2002, Vol.47, p.S162-S175</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,4025</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13872582$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>STJERNSCHANTZ, Johan W</creatorcontrib><creatorcontrib>ALBERT, Daniel M</creatorcontrib><creatorcontrib>HU, Dan-Ning</creatorcontrib><creatorcontrib>DRAGO, Filippo</creatorcontrib><creatorcontrib>WISTRAND, Per J</creatorcontrib><title>Mechanism and clinical significance of prostaglandin-induced iris pigmentation: Update on the use of prostaglandin analogs in glaucoma therapy</title><title>Survey of ophthalmology</title><subject>Biological and medical sciences</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Eye</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Toxicity: eye</subject><issn>0039-6257</issn><issn>1879-3304</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqNjLsOgjAUQBujifj4hy6OTQoFgdloXHRyJ01p8ZpyaXpx8O_t4Ac4nTOcnAXL8qZuhVKyXLJMStWKY1HVa7YhekkpS9XWGbvfrHlqBBq5xp4bDwhGe04wILikaCyfHA9xolkPPkWAArB_G9tziEA8wDBanPUME-7YymlPdv_jlh0u58fpKoKmtHUx_YC6EGHU8dPlqqmLqinUv90XWBBCZw</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>STJERNSCHANTZ, Johan W</creator><creator>ALBERT, Daniel M</creator><creator>HU, Dan-Ning</creator><creator>DRAGO, Filippo</creator><creator>WISTRAND, Per J</creator><general>Elsevier Science</general><scope>IQODW</scope></search><sort><creationdate>2002</creationdate><title>Mechanism and clinical significance of prostaglandin-induced iris pigmentation</title><author>STJERNSCHANTZ, Johan W ; ALBERT, Daniel M ; HU, Dan-Ning ; DRAGO, Filippo ; WISTRAND, Per J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_138725823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Biological and medical sciences</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Eye</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Toxicity: eye</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>STJERNSCHANTZ, Johan W</creatorcontrib><creatorcontrib>ALBERT, Daniel M</creatorcontrib><creatorcontrib>HU, Dan-Ning</creatorcontrib><creatorcontrib>DRAGO, Filippo</creatorcontrib><creatorcontrib>WISTRAND, Per J</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Survey of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>STJERNSCHANTZ, Johan W</au><au>ALBERT, Daniel M</au><au>HU, Dan-Ning</au><au>DRAGO, Filippo</au><au>WISTRAND, Per J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanism and clinical significance of prostaglandin-induced iris pigmentation: Update on the use of prostaglandin analogs in glaucoma therapy</atitle><jtitle>Survey of ophthalmology</jtitle><date>2002</date><risdate>2002</risdate><volume>47</volume><spage>S162</spage><epage>S175</epage><pages>S162-S175</pages><issn>0039-6257</issn><eissn>1879-3304</eissn><coden>SUOPAD</coden><cop>New York, NY</cop><pub>Elsevier Science</pub></addata></record>
fulltext fulltext
identifier ISSN: 0039-6257
ispartof Survey of ophthalmology, 2002, Vol.47, p.S162-S175
issn 0039-6257
1879-3304
language eng
recordid cdi_pascalfrancis_primary_13872582
source Elsevier ScienceDirect Journals
subjects Biological and medical sciences
Drug toxicity and drugs side effects treatment
Eye
Medical sciences
Pharmacology. Drug treatments
Toxicity: eye
title Mechanism and clinical significance of prostaglandin-induced iris pigmentation: Update on the use of prostaglandin analogs in glaucoma therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T13%3A59%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanism%20and%20clinical%20significance%20of%20prostaglandin-induced%20iris%20pigmentation:%20Update%20on%20the%20use%20of%20prostaglandin%20analogs%20in%20glaucoma%20therapy&rft.jtitle=Survey%20of%20ophthalmology&rft.au=STJERNSCHANTZ,%20Johan%20W&rft.date=2002&rft.volume=47&rft.spage=S162&rft.epage=S175&rft.pages=S162-S175&rft.issn=0039-6257&rft.eissn=1879-3304&rft.coden=SUOPAD&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E13872582%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true